Fracture (FX) Improvement With Teriparatide: FiX-IT Study
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This open label comparison study examines the hypothesis that teriparatide given immediately
following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will
enhance healing and improve bone mineral density compared to delayed treatment (after six
months) with teriparatide or no treatment with teriparatide (patients who refuse therapy or
for whom teriparatide is contraindicated). Patients with up-front teriparatide in addition
will have greater quality of life measures and less pain compared to those with delayed or no
therapy.